| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.3M | +25.4% |
| SG&A Expense | $28.9M | +11.4% |
| Income Tax | $0 | — |
| Net Income | -$63.7M | -9.9% |
| EPS (Basic) | -$0.51 | -10.9% |
| EPS (Diluted) | -$0.51 | -10.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.4M | -83.1% |
| Current Assets | $176.8M | -5.5% |
| Total Assets | $305.6M | -12.7% |
| Current Liabilities | $9.1M | +34.3% |
| Total Liabilities | $40.2M | +14.5% |
| Stockholders' Equity | $265.4M | -15.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.7M | -12.9% |
| Capital Expenditures | $2.4M | +5.1% |
| Investing Cash Flow | -$43.7M | -69.9% |
| Financing Cash Flow | $368K | -34.5% |
| Free Cash Flow | -$54.2M | -12.5% |